USPTO 2015–2025 USPTO PatentsView US Corporation

Carefusion 303, Inc.

USPTO PatentsView assignee record - 711 granted patents across 79 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

711
Total patents granted
79
CPC technology areas
17.1
Avg claims per patent
+109%
5-year filing velocity

The verdict

Carefusion holds 711 US patents across 79 technology areas, rank #621 of 50,000 tracked assignees.

#621
of 50,000 US assignees by volume
Top 1%
by Innovation Score (68.7/100)
17.1
avg claims per patent
+109%
filing velocity, last 5 yrs

Portfolio overview

Carefusion 303, Inc. has been granted 711 US utility patents between 2015 and 2025, placing Carefusion 303, Inc. at rank #621 across all assignees tracked by PlainPatent. This portfolio spans 79 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.1 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Carefusion 303, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Carefusion sits between T-mobile Innovations Llc (715 patents, rank #617) and CJ Cheiljedang Corporation (709 patents, rank #625) - the closest US assignees by grant volume. The composite Innovation Score of 68.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 481 grants, compared with 230 in the 2015–2019 window, a +109% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Carefusion 303, Inc.'s 17.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 79 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Carefusion 303, Inc. against peers pursuing similar technology classes.

Who files at Carefusion's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Carefusion holds 711 patents at rank #621, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Carefusion

By rank, the assignees closest to #621 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Carefusion's primary technology class.

Carefusion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

69 Top 1% higher than 99% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

20406080100120 20152016201720182019202020212022202320242025 77
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Carefusion 303, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 45 6.3%
2016 46 6.5%
2017 40 5.6%
2018 42 5.9%
2019 57 8.0%
2020 52 7.3%
2021 67 9.4%
2022 86 12.1%
2023 100 14.1%
2024 99 13.9%
2025 77 10.8%

Which technologies does Carefusion 303, Inc. patent most?

Top 15 of 79 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#621

Across all tracked assignees

Innovation Score

68.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Carefusion 303, Inc. hold?
Carefusion 303, Inc. holds 711 US granted patents filed between 2015 and 2025, spanning 79 technology areas.
What is Carefusion 303, Inc.'s Innovation Score?
Carefusion 303, Inc. has an Innovation Score of 68.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Carefusion 303, Inc. focus on?
Carefusion 303, Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 419 patents. The company has filed patents in 79 CPC subclasses total.
Is Carefusion 303, Inc.'s patent filing rate increasing or decreasing?
Carefusion 303, Inc.'s recent filing velocity is +109% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Carefusion 303, Inc.'s patents?
Carefusion 303, Inc.'s patents average 17.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the Carefusion 303, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Carefusion's 711 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Carefusion ranks #621 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.